Influence of DIP for TCM Dominant Diseases on the Operation of Public TCM Hospitals

China Health Insurance ›› 2022, Vol. 0 ›› Issue (12) : 78-81.

China Health Insurance ›› 2022, Vol. 0 ›› Issue (12) : 78-81. DOI: 10.19546/j.issn.1674-3830.2022.12.014
Management Platform

Influence of DIP for TCM Dominant Diseases on the Operation of Public TCM Hospitals

Author information +
History +

Abstract

Objective: This paper analyzes the influence of dominant diseases of traditional Chinese medicineon the operation of public TCM hospitals after Shenzhen has incorporated them into the Diagnosis-Intervention Packet. Methods: Taking the medical records of DIP inpatients from2020to2021in a3A public hospital of TCM as the research sample, this paper analyzes the basic situation of four categories of diseases, the implementation of the dominant diseases of TCM. Descriptive statistics is used to analyze the dominant diseases of TCM in different groups. Results: The cost management effect of the dominant diseases of TCM is good, the hospital's revenue, expenditure is balanced, with a slight balance. However, there are also problems, for example, doctors are not motivated, the payment method does not reflect the dominant diseases of outpatient TCM. Conclusion: TCM hospitals should enhance the dominant diseases of TCM, improve competitiveness. Medical insurance payment reform should be in line with the performance appraisal of doctors, adhere to the "same disease, same effect, same price" of Chinese, western medicine, move towards paying according to curative therapeutic effect

Key words

DIP / dominant diseases of TCM / public TCM hospital / operation

Cite this article

Download Citations
Influence of DIP for TCM Dominant Diseases on the Operation of Public TCM Hospitals[J]. China Health Insurance. 2022, 0(12): 78-81 https://doi.org/10.19546/j.issn.1674-3830.2022.12.014

References

[1] 广东省医疗保障局,深圳市医疗保障局.深圳医保支付政策支持中医优势病种发展促进中医药守正创新[EB/OL].(2021-04-09)[2022-11-01] .http://hsa.gd.gov.cn/gab/gddt/content/post_3514712.html.
[2] 季聪华,郭清.基于循证医学的中医优势病种评价标准思考[J].中华中医药杂志,2022,37(1):277-280.
[3] 深圳市医疗保障局.关于印发《深圳市社会医疗保险定点医药机构医疗费用支付办法》的通知[EB/OL].(2020-03-27)[2022-11-01] .http://www.sz.gov.cn/zfgb/zcjd/content/post_7061748.html.
[4] 郭丹丹,苏宇,彭凯,等.“循证+价值”驱动下的中医药医保支付制度创新[J]. 中国卫生经济,2016,35(8):33-34.
[5] 谭清立,刘思妍,柳丹玲,等.按病种分值付费对医生行为的影响——基于实验经济学[J].中国卫生政策研究,2021,14(9):14-19.
[6] 广东省医疗保障局.关于开展医保支付改革促进中医药传承创新发展的指导意见的通知[EB/OL].(2021-10-11)[2022-11-01] .http://hsa.gd.gov.cn/gkmlpt/content/3/3559/post_3559792.html#445.
[7] 张计美,孟文竹.DIP付费对公立医院运营管理的影响探析[J].商业会计,2021(15):103-106.
[8] 刘颖. "两个允许"背景下公立医院薪酬体系建设研究[J].卫生经济研究,2018(10):63-66.
[9] 国家医疗保障局,柳州市医疗保障局.全国医疗保障经办服务“学党史办实事”优秀典型案例|广西壮族自治区柳州市医疗保障事业管理中心探索医保疗效价值付费促进中医传承创新发展[EB/OL].(2021-12-30)[2022-12-07] .http://www.nhsa.gov.cn/art/2021/12/30/art_131_7709.html.
[10] 黄成凤,申丽君,杨燕绥.价值导向型医保付费政策效果探讨——基于柳州市中医优势病种的实证分析[J]. 卫生经济研究,2022,39(5):37-41.

Accesses

Citation

Detail

Sections
Recommended

/